More than 75% of the clear cell in renal cell carcinoma patients contained elevated levels of IDO [15] which was also observed in CKD patients, and IDO activity was correlated with disease severity and levels of inflammatory markers [16]. Here, IDO1 is linked to hereditary clear cell renal cell carcinoma.